StreetInsider.com News Articles

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announced today that Likozam® (clobazam) is reimbursed by the French social security system, notably for the combination treatment of drug-resistant epilepsy.

The price of Likozam® in France,

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

The price of Likozam® in France,

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

The price of Likozam® in France,

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

The price of Likozam® in France,

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

The price of Likozam® in France,

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

The price of Likozam® in France,

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

The price of Likozam® in France,

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Mon, 01 Jun 2026 01:45:00 -0400

Likozam® will be reimbursed to patients starting June 12, 2026
Official reimbursement ends the “Early Access” clawback
The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

PARIS--(BUSINESS WIRE)-- Regulatory News:

The price of Likozam® in France,

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

The AGM, held in Paris on May 21, 2026, adopted all the resolutions regarding the approval of the Company’s financial statements, the granting of financial delegations to the Board of Directors, and the delegations and authorizations permitting the allocation of warrants and free shares of the Company. The voting results for each resolution are

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

Advicenne Announces Changes to Its Governance Following Its Annual General Meeting on May 21, 2026

Thu, 21 May 2026 15:02:00 -0400

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 -ALDVI), a pharmaceutical company specializing in the development and marketing of innovativetreatments for people suffering from rare kidney diseases, announces changes to its governance following its Annual General Meeting (AGM) held on May 21, 2026.

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal

Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway

Tue, 05 May 2026 16:07:00 -0400

A proactive initiative to restructure the Company’s debt
A protective framework that allows for the continuation of commercial, clinical, and regulatory activities, as well as discussions with potential partners
A financing plan currently being finalized to extend the cash runway through the end of Q1 2027

PARIS--(BUSINESS WIRE)-- Regulatory News:

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal